Metraipolis › archive › dc_2555b91bd2f7

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada — Europe PMC PMID:41449712

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41449712
DOI
10.1002/pds.70302
License (as archived)
solo-consultazione
Archived
2026-11-07T03:51:35.657Z
SHA-256 of the archived text
68daae887d206994fc8d8c923de1885be76254f213be8ce5b9c5eecacb42711d
Stable URL of this page
https://metraipolis.com/documento/dc_2555b91bd2f7

How to cite

Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada — Europe PMC PMID:41449712 — Europe PMC (en), https://europepmc.org/article/MED/41449712 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2555b91bd2f7 (Metraipolis archive dc_2555b91bd2f7, sha256 68daae887d206994fc8d8c923de1885be76254f213be8ce5b9c5eecacb42711d)
BibTeX
@misc{dc2555b91bd2f7,
  title = {Eligibility for Nirmatrelvir/Ritonavir Among Adults With an Acute Care COVID-19 Encounter: A Retrospective Cohort Study From Alberta, Canada — Europe PMC PMID:41449712},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41449712},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2555b91bd2f7; sha256 68daae887d206994fc8d8c923de1885be76254f213be8ce5b9c5eecacb42711d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41449712. Agents can read the archived copy with the MCP tool read_document.